A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19

NCT04646590 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

28904

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of COVID-19
Safety and Efficacy

Interventions

BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell) group
BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cells) placebo group

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.